Literature DB >> 6801218

Effect of intracranial pressure monitoring and aggressive treatment on mortality in severe head injury.

T G Saul, T B Ducker.   

Abstract

During 1977-1978, 127 patients with severe head injury were admitted and underwent intracranial pressure (ICP) monitoring. All patients had Glasgow Coma Scale (GCS) scores of 7 or less. All received identical initial treatment according to a standardized protocol. The patients' average age was 29 years; 60% had multiple trauma, and 35% needed emergency intracranial operations. Treatment for elevations of ICP was begun when ICP rose to 20 to 25 mm Hg, and included mannitol therapy and drainage of cerebrospinal fluid (CSF) when possible. Forty-three patients (34%) had ICP greater than or equal to 25 mm Hg; of these, 36 (84%) died. The mortality rate of the entire group was 46%. During 1979-1980, 106 patients with severe head injury were admitted and underwent ICP monitoring. Their average ager was 29 years; 51% had multiple trauma, and 31% underwent emergency intracranial surgery. All patients received the same standardized protocol as the previous series, with the exception of the treatment of ICP. In this present series: if ICP was 15 mm Hg or less (normal ICP), patients were continued on hyperventilation, steroids, and intensive care; if ICP was 16 to 24 mm Hg, mannitol was administered and CSF was drained; if ICP was 25 mm Hg or greater, the patients were randomized into a controlled barbiturate therapy study. Twenty-six patients (25%) had ICP's of 25 mm Hg or greater, compared to 34% in the previous series (p less than 0.05), and 18 of these 26 patients (69%) died. The overall mortality for this current series was 28% compared to 46% in the previous series (p less than 0.0005). This study reconfirms the high mortality rate if ICP is 25 mm Hg or greater; however, the data also document that early aggressive treatment based on ICP monitoring significantly lessens the incidence of ICP of 25 mm Hg or greater and reduces the overall mortality rate of severe head injury.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6801218     DOI: 10.3171/jns.1982.56.4.0498

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  66 in total

1.  Complications of brain tissue pressure monitoring with a fiberoptic device.

Authors:  A Bekar; S Gören; E Korfali; K Aksoy; S Boyaci
Journal:  Neurosurg Rev       Date:  1998       Impact factor: 3.042

2.  Ghrelin prevents disruption of the blood-brain barrier after traumatic brain injury.

Authors:  Nicole E Lopez; Michael J Krzyzaniak; Chelsea Blow; James Putnam; Yan Ortiz-Pomales; Ann-Marie Hageny; Brian Eliceiri; Raul Coimbra; Vishal Bansal
Journal:  J Neurotrauma       Date:  2011-10-26       Impact factor: 5.269

3.  Evaluation of minimally invasive percutaneous CT-controlled ventriculostomy in patients with severe head trauma.

Authors:  M Krötz; U Linsenmaier; K G Kanz; K J Pfeifer; W Mutschler; M Reiser
Journal:  Eur Radiol       Date:  2003-11-06       Impact factor: 5.315

Review 4.  Biomarkers in neurocritical care.

Authors:  W Taylor Kimberly
Journal:  Neurotherapeutics       Date:  2012-01       Impact factor: 7.620

5.  The effects of indomethacin on intracranial pressure, cerebral blood flow and cerebral metabolism in patients with severe head injury and intracranial hypertension.

Authors:  K Jensen; J Ohrström; G E Cold; J Astrup
Journal:  Acta Neurochir (Wien)       Date:  1991       Impact factor: 2.216

Review 6.  The management of acute severe head injury.

Authors:  T J Coonan
Journal:  Can J Anaesth       Date:  1989-05       Impact factor: 5.063

7.  An approach to determining intracranial pressure variability capable of predicting decreased intracranial adaptive capacity in patients with traumatic brain injury.

Authors:  Jun-Yu Fan; Catherine Kirkness; Paolo Vicini; Robert Burr; Pamela Mitchell
Journal:  Biol Res Nurs       Date:  2010-04       Impact factor: 2.522

8.  Dose-dependent rate of nosocomial pulmonary infection in mechanically ventilated patients with brain oedema receiving barbiturates: a prospective case study.

Authors:  K E Eberhardt; B M Thimm; A Spring; W R Maskos
Journal:  Infection       Date:  1992 Jan-Feb       Impact factor: 3.553

Review 9.  What type of monitoring has been shown to improve outcomes in acutely ill patients?

Authors:  Gustavo A Ospina-Tascón; Ricardo L Cordioli; Jean-Louis Vincent
Journal:  Intensive Care Med       Date:  2008-01-05       Impact factor: 17.440

10.  Therapeutic targeting of astrocytes after traumatic brain injury.

Authors:  Jessica Shields; Donald E Kimbler; Walid Radwan; Nathan Yanasak; Sangeetha Sukumari-Ramesh; Krishnan M Dhandapani
Journal:  Transl Stroke Res       Date:  2011-11-09       Impact factor: 6.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.